Who
Joshua Hare
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Longeveron.
In numbers
- Trades disclosed
- 45
- Buys
- 7
- Sells
- 6
- Bought
- $1.5M
- Sold
- $729K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Feb 2021
- Last trade
- 19 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —286,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —286,000 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,000 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,219 at $0.00 | filing |
| 13 Jun 2025filed 17 Jun 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —184,878 at $0.00 | filing |
| 13 Jun 2025filed 17 Jun 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,254 at $0.00 | filing |
| 16 May 2025filed 16 May 2025 | LGVN LongeveronBiotechnology | SEC FORM 4 Sold | $7,3505,250 at $1.40 | filing |
| 4 Mar 2025filed 6 Mar 2025 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,254 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Code A | —93,766 at $0.00 | filing |
| 11 Apr 2024filed 12 Apr 2024 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code P | $5,53242,553 at $0.13 | filing |
| 11 Apr 2024filed 12 Apr 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Bought | $100K42,553 at $2.35 | filing |
| 10 Apr 2024filed 12 Apr 2024 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code P | $14K106,383 at $0.13 | filing |
| 10 Apr 2024filed 12 Apr 2024 | LGVN LongeveronBiotechnology | SEC FORM 4 Bought | $250K106,383 at $2.35 | filing |
| 21 Dec 2023filed 26 Dec 2023 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 21 Sep 2023filed 22 Sep 2023 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.